GABRD and adrenal cortex carcinoma: Kaplan-Meier estimates showed that upregulation of tumoral GABRD transcripts was negatively prognostic for overall (Figure 6c) and progression-free survival (Figure 6d) in ACC patients relative to those patients with unaltered GABRD. Median survival of patients with upregulated vs unaltered tumoral GABRD transcripts was 18 vs 79 months for overall survival; 8 vs 78 months for progression-free survival.